Send to

Choose Destination
See comment in PubMed Commons below
N Engl J Med. 2011 Jul 28;365(4):285-7. doi: 10.1056/NEJMp1106689. Epub 2011 Jun 15.

Weighing the benefits of high-dose simvastatin against the risk of myopathy.

Author information

  • 1Division of Metabolism and Endocrinology Products, Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA.
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon
    Loading ...
    Write to the Help Desk